12
IRUS Total
Downloads

COX inhibitors and breast cancer

File Description SizeFormat 
COX inhibitors and breast cancer.pdfPublished version159.16 kBAdobe PDFView/Open
Title: COX inhibitors and breast cancer
Authors: Mazhar, D
Ang, R
Waxman, J
Item Type: Journal Article
Issue Date: 13-Feb-2006
URI: http://hdl.handle.net/10044/1/52685
DOI: https://dx.doi.org/10.1038/sj.bjc.6602942
ISSN: 0007-0920
Publisher: NATURE PUBLISHING GROUP
Start Page: 346
End Page: 350
Journal / Book Title: BRITISH JOURNAL OF CANCER
Volume: 94
Issue: 3
Copyright Statement: From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
Keywords: Science & Technology
Life Sciences & Biomedicine
Oncology
ONCOLOGY
cyclo-oxygenase (COX)
prostaglandin
breast cancer
NSAIDS
selective COX-2 inhibitor
NONSTEROIDAL ANTIINFLAMMATORY DRUGS
ELEVATED CYCLOOXYGENASE-2 EXPRESSION
GASTROINTESTINAL TOXICITY
MAMMARY TUMORIGENESIS
RHEUMATOID-ARTHRITIS
GENE-EXPRESSION
TRANSGENIC MICE
CELECOXIB
RISK
CARCINOGENESIS
Breast Neoplasms
Clinical Trials as Topic
Cyclooxygenase 2
Cyclooxygenase 2 Inhibitors
Female
Humans
Incidence
Treatment Outcome
1112 Oncology And Carcinogenesis
Oncology & Carcinogenesis
Publication Status: Published
Appears in Collections:Department of Surgery and Cancer